KRYSTAL BIOTECH INC (KRYS) Institutional Ownership Changes & 13F Activity
KRYSTAL BIOTECH INC (KRYS). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q2 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Bellevue Group Ag, Invesco Ltd., Price T Rowe Associates Inc, Goldman Sachs Group Inc, and Braidwell Lp.
| Institution | Type | Change in shares | Change Position % | Shares | Reported stock balance | Portfolio quarter | Filing date |
|---|---|---|---|---|---|---|---|
| Neuberger Berman Group Llc | Buy | +18,792 | +56.8% | 51,876 | $19.28M | Q2 2026 | Oct 27, 2026 |
| Gibbs Wealth Management | Buy | +774 | — | 774 | $287.67K | Q2 2026 | Oct 21, 2026 |
| Envestnet Asset Management Inc | Buy | +1,229 | +10.3% | 13,212 | $4.91M | Q2 2026 | Sep 23, 2026 |
| Qrg Capital Management, Inc. | Buy | +220 | +17.2% | 1,501 | $557.88K | Q2 2026 | Sep 23, 2026 |
| State Street Corp | Buy | +36,724 | +2.8% | 1,351,158 | $502.20M | Q2 2026 | Sep 22, 2026 |
| Manufacturers Life Insurance Company, The | Sell | -10,202 | -28.3% | 25,867 | $9.61M | Q2 2026 | Sep 09, 2026 |
| Parkside Financial Bank & Trust | Buy | +15 | +44.1% | 49 | $18.21K | Q2 2026 | Sep 04, 2026 |
| Allianz Asset Management Gmbh | Buy | +10,831 | +570.1% | 12,731 | $4.73M | Q2 2026 | Sep 02, 2026 |
| Citadel Advisors Llc | Sell | -1 | -0.0% | 2,725 | $1.01M | Q2 2026 | Sep 02, 2026 |
| Corient Private Wealth Llc | Buy | +27,035 | +767.4% | 30,558 | $11.36M | Q2 2026 | Aug 27, 2026 |
| Optimize Financial Inc | Sell | -5 | -0.3% | 1,705 | $633.70K | Q2 2026 | Aug 27, 2026 |
| California State Teachers Retirement System | Sell | -2,494 | -9.5% | 23,692 | $8.81M | Q2 2026 | Aug 24, 2026 |
| Bernard Wealth Management Corp. | Buy | +130 | — | 130 | $48.32K | Q2 2026 | Aug 21, 2026 |
| Archer Investment Corp | Buy | +100 | +13.7% | 830 | $308.49K | Q2 2026 | Aug 19, 2026 |
| Fulcrum Asset Management Llp | Buy | +28 | — | 28 | $10.59K | Q2 2026 | Aug 18, 2026 |
| Seven Fleet Capital Management Lp | Sell | -2,542 | -58.9% | 1,774 | $659.34K | Q2 2026 | Aug 17, 2026 |
| Empowered Funds, Llc | Buy | +49 | +2.2% | 2,325 | $864.13K | Q2 2026 | Aug 17, 2026 |
| Strive Financial Group ,Llc | Buy | +1 | — | 1 | $372.00 | Q2 2026 | Aug 17, 2026 |
| Bellevue Group Ag | Sell | -404,255 | -83.9% | 77,530 | $28.82M | Q2 2026 | Aug 14, 2026 |
| Invesco Ltd. | Buy | +324,755 | — | 324,755 | $120.70M | Q2 2026 | Aug 14, 2026 |
| Price T Rowe Associates Inc | Buy | +202,326 | +41.7% | 687,400 | $255.49M | Q2 2026 | Aug 14, 2026 |
| Goldman Sachs Group Inc | Buy | +83,892 | +39.0% | 298,841 | $111.07M | Q2 2026 | Aug 14, 2026 |
| Braidwell Lp | Sell | -53,450 | -29.3% | 128,975 | $47.94M | Q2 2026 | Aug 14, 2026 |
| Ameriprise Financial Inc | Buy | +48,790 | — | 48,790 | $18.13M | Q2 2026 | Aug 14, 2026 |
| Hood River Capital Management Llc | Buy | +43,789 | +7.1% | 663,375 | $246.56M | Q2 2026 | Aug 14, 2026 |
| Redmile Group, Llc | Sell | -41,500 | -6.2% | 632,005 | $234.90M | Q2 2026 | Aug 14, 2026 |
| Wellington Management Group Llp | Buy | +26,709 | +261.2% | 36,936 | $13.73M | Q2 2026 | Aug 14, 2026 |
| Wells Fargo & Company/Mn | Buy | +19,514 | +130.2% | 34,502 | $12.82M | Q2 2026 | Aug 14, 2026 |
| Van Eck Associates Corp | Buy | +17,071 | — | 17,071 | $6.34M | Q2 2026 | Aug 14, 2026 |
| Castleark Management Llc | Sell | -15,480 | -48.9% | 16,150 | $6.00M | Q2 2026 | Aug 14, 2026 |
Frequently asked questions about KRYS activity
Which institutional owners are buying KRYS?
Institutional owners buying KRYS include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in KRYS activity?
"Buy" means an investor increased their reported position in KRYS compared to the prior reporting period. This reflects growing exposure to KRYSTAL BIOTECH INC (KRYS) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in KRYS increasing?
Institutional interest in KRYS can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.
Related KRYS Institutional Insights
- KRYS Overview
- KRYS 13F Institutional Holders
- KRYS Superinvestors
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- KRYS Insider Trading & SEC Form 4 Activity
- KRYS Articles
- Top Institutional Investor Stock Rankings